ADC Therapeutics SA (NYSE:ADCT)
| 26.14 BATS BZX Real-Time Price As of 12:42pm ET |  -0.94 / -3.47%Today’s Change | 25.11 Today|||52-Week Range 56.59 | -18.34% Year-to-Date |
Latest ADCT News | Press Releases
| Why ADC Therapeutics (ADCT) Might Surprise This Earnings Season 8:44am / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 27.08 |
| Today’s open | 26.80 |
| Day’s range | 26.01 - 26.80 |
| Volume | 137,470 |
| Average volume (3 months) | 228,391 |
| Market cap | $2.0B |
Data as of 12:42pm ET, 03/03/2021
Growth & Valuation
| Earnings growth (last year) | +99.99% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -14.94% |
| Revenue growth (last year) | +105.26% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 16.00 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | June 2, 2021 |
| EPS forecast (this quarter) | -$0.43 |
| Annual revenue (last year) | $2.3M |
| Annual profit (last year) | -$116.5M |
| Net profit margin | -4,977.95% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
